US Bancorp DE Sells 613 Shares of Stevanato Group S.p.A. (NYSE:STVN)

US Bancorp DE trimmed its stake in Stevanato Group S.p.A. (NYSE:STVN) by 7.8% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 7,232 shares of the company’s stock after selling 613 shares during the period. US Bancorp DE’s holdings in Stevanato Group were worth $145,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of STVN. Tri Locum Partners LP acquired a new position in shares of Stevanato Group during the second quarter valued at $10,370,000. Thrivent Financial for Lutherans acquired a new stake in Stevanato Group during the 2nd quarter worth $30,477,000. Thornburg Investment Management Inc. lifted its holdings in shares of Stevanato Group by 279.1% during the 2nd quarter. Thornburg Investment Management Inc. now owns 746,218 shares of the company’s stock valued at $13,690,000 after purchasing an additional 549,378 shares in the last quarter. Comgest Global Investors S.A.S. increased its stake in Stevanato Group by 56.8% during the 2nd quarter. Comgest Global Investors S.A.S. now owns 394,120 shares of the company’s stock worth $7,228,000 after purchasing an additional 142,754 shares in the last quarter. Finally, Raymond James Trust N.A. lifted its stake in Stevanato Group by 18.7% in the second quarter. Raymond James Trust N.A. now owns 10,239 shares of the company’s stock valued at $188,000 after buying an additional 1,613 shares in the last quarter.

Wall Street Analysts Forecast Growth

Separately, Citigroup decreased their price objective on Stevanato Group from $30.00 to $28.00 and set a “buy” rating for the company in a report on Wednesday, August 7th.

Stevanato Group Price Performance

STVN stock opened at €19.00 ($20.00) on Friday. The company has a 50 day simple moving average of €19.56 and a 200 day simple moving average of €20.05. Stevanato Group S.p.A. has a 1 year low of €16.56 ($17.43) and a 1 year high of €34.73 ($36.56). The company has a current ratio of 1.81, a quick ratio of 1.21 and a debt-to-equity ratio of 0.22.

Stevanato Group (NYSE:STVN) last released its quarterly earnings results on Tuesday, November 5th. The company reported €0.12 ($0.13) earnings per share (EPS) for the quarter, missing the consensus estimate of €0.13 ($0.14) by (€0.01) (($0.01)). Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. The firm had revenue of €277.90 million for the quarter, compared to the consensus estimate of €274.36 million. During the same quarter in the previous year, the business posted $0.16 EPS. The firm’s revenue for the quarter was up 2.4% compared to the same quarter last year. On average, analysts anticipate that Stevanato Group S.p.A. will post 0.5 EPS for the current fiscal year.

Stevanato Group Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.